Sale of the Toda site of Tanabe Mitsubishi Pharma
First written in FY2020-Q3. 1 of 2 entries say "Achieved", first in FY2020. Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020AchievedAnnual report
「The sale of the asset was completed on 24 April 2020.」
The real estate sale of Tanabe Mitsubishi Pharma's Toda site, for which the agreement and planned sale had been disclosed in the previous filing, was completed on 24 April 2020. - FY2020-Q3First statedAnnual report
「At the end of the third quarter of the current consolidated fiscal year, assets held for sale and liabilities directly related to them primarily resulted from the conclusion of a real estate sale and purchase agreement for the Toda site of Tanabe Mitsubishi Pharma Co., Ltd., a consolidated subsidiary of the company in the Healthcare segment. As the fair value of the Toda site less costs to sell, or its expected sale price, exceeds its carrying amount, the asset is measured at its carrying amount. The asset is scheduled to be sold within one year from the end of the second quarter of the current consolidated fiscal year.」
The company concluded a real estate sale and purchase agreement for the Toda site of Tanabe Mitsubishi Pharma and classified it as held for sale. The site is scheduled to be sold within one year from the end of the second quarter.